Multicentric, Transversal, Descriptive, Epidemiological Study on the Management of Asthma in Asthmatic Middle East Adult Population (ESMAA)

AstraZeneca

Status: Completed

Conditions: Asthma

Study type: Observational

Funder types: Industry

Identifiers

NCT02153411

NIS-RME-XXX-2014/1 (Registry Identifier)

Details and patient eligibility

About

Descriptive study on the management of asthma in asthmatic Middle East adult population : Algeria,Egypt, Irak,Iran, Jordan, Koweit, Lebanon, Qatar,Saudi,Tunisia, UAE

Full description

Multicentric, transversal, descriptive, epidemiological study, conducted in a random sample of general practitioner and medical specialist (Pulmonologist and/or allergologist) in the public and the private sector.

Enrollment: 7,294 patients

Sex: All

Ages: 18 to 130 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Men and women, 18 years of age and older. Asthmatic since at least one year before inclusion. Patient's informed consent obtained.

Exclusion criteria

• Patient concurrently participating to another study. Patient with concomitant pulmonary disease. Patient with psychiatric disorders. Patient consulting for an asthma attack

Trial design

7,294 participants in 1 patient group

8645 asthmatic patients

Description:

Men and women, 18 years of age and older. Asthmatic since at least one year before inclusion. Patient's informed consent obtained.